Steve N. Slilaty is Chief Executive Officer of Sunshine Biopharma, Inc.. Currently has a direct ownership of 130,000 shares of SBFM, which is worth approximately $412,100. The most recent transaction as insider was on Mar 04, 2024, when has been sold 100,000 shares (Series B Preferred Stock) at a price of $0.1 per share, resulting in proceeds of $10,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130K
0% 3M change
n/a 12M change
Total Value Held $412,100

Steve N. Slilaty Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2024
BUY
Open market or private purchase
$10,000 $0.1 p/Share
100,000 Added 43.48%
130,000 Series B Preferred Stock
Feb 08 2024
BUY
Open market or private purchase
$2,000 $0.1 p/Share
20,000 Added 40.0%
30,000 Series B Preferred Stock
SNS

Steve N. Slilaty

Chief Executive Officer
New York, NY

Track Institutional and Insider Activities on SBFM

Follow Sunshine Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBFM shares.

Notify only if

Insider Trading

Get notified when an Sunshine Biopharma, Inc. insider buys or sells SBFM shares.

Notify only if

News

Receive news related to Sunshine Biopharma, Inc.

Track Activities on SBFM